Tobira Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tobira Therapeutics, Inc..The latest application filed is for "purified cenicriviroc and purified intermediates for making cenicriviroc".

Company Profile

18.13.29

Tobira Therapeutics, Inc. - Parsippany NJ US
Tobira Therapeutics, Inc. - South San Francisco CA US
TOBIRA THERAPEUTICS, INC. - San Jose CA
Tobira Therapeutics, Inc. - Princeton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Purified cenicriviroc and purified intermediates for making cenicriviroc App 20210171504 - Morra; Nicholas ; et al.	2021-06-10
Cenicriviroc For The Treatment Of Fibrosis App 20200368247 - Lefebvre; Eric	2020-11-26
Cenicriviroc For The Treatment Of Fibrosis App 20200360347 - Lefebvre; Eric	2020-11-19
Bicyclic Compound, Production And Use Thereof App 20200297700 - SHIRAISHI; Mitsuru ; et al.	2020-09-24
Cenicriviroc Combination Therapy For The Treatment Of Fibrosis App 20200268768 - Lefebvre; Eric	2020-08-27
Process Of Making Cenicriviroc And Related Analogs App 20200216476 - Morra; Nicholas	2020-07-09
Purified cenicriviroc and purified intermediates for making cenicriviroc App 20200095229 - Morra; Nicholas ; et al.	2020-03-26
Process of making cenicriviroc and related analogs Grant 10,526,349 - Morra J	2020-01-07
Cenicriviroc Combination Therapy For The Treatment Of Fibrosis App 20200000772 - Lefebvre; Eric	2020-01-02
Cenicriviroc For The Treatment Of Fibrosis App 20190343806 - Lefebvre; Eric	2019-11-14
Purified cenicriviroc and purified intermediates for making cenicriviroc Grant 10,407,411 - Morra , et al. Sept	2019-09-10
Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate Grant 10,301,287 - Phiasivongsa , et al.	2019-05-28
Cenicriviroc For The Treatment Of Fibrosis App 20190099429 - Lefebvre; Eric	2019-04-04
Bicyclic Compound, Production And Use Thereof App 20190038604 - SHIRAISHI; Mitsuru ; et al.	2019-02-07
Cenicriviroc Combination Therapy For The Treatment Of Fibrosis App 20180360846 - LEFEBVRE; Eric	2018-12-20
Process Of Making Cenicriviroc And Related Analogs App 20180327428 - MORRA; Nicholas	2018-11-15
Bicyclic compound, production and use thereof Grant 10,045,968 - Shiraishi , et al. August 14, 2	2018-08-14
Cenicriviroc For The Treatment Of Fibrosis App 20180110754 - LEFEBVRE; Eric	2018-04-26
Solid Forms Of Cenicriviroc Mesylate And Processes Of Making Solid Forms Of Cenicriviroc Mesylate App 20180057481 - PHIASIVONGSA; Pasit ; et al.	2018-03-01
Purified Cenicriviroc And Purified Intermediates For Making Cenicriviroc App 20170362207 - MORRA; Nicholas ; et al.	2017-12-21
Cenicriviroc Combination Therapy For The Treatment Of Fibrosis App 20170319548 - LEFEBVRE; Eric	2017-11-09
Cenicriviroc For The Treatment Of Fibrosis App 20170239262 - LEFEBVRE; Eric	2017-08-24
Lamivudine salts Grant 9,688,666 - Dalziel , et al. June 27, 2	2017-06-27
Cenicriviroc For The Treatment Of Hiv-2 Infection App 20170105969 - LEFEBVRE; Eric	2017-04-20
Cenicriviroc Compositions And Methods Of Making And Using The Same App 20160081985 - Menning; Mark Michael ; et al.	2016-03-24
Bicyclic Compound, Production And Use Thereof App 20160008326 - SHIRAISHI; Mitsuru ; et al.	2016-01-14
Lamivudine Salts App 20150368232 - DALZIEL; Sean Mark ; et al.	2015-12-24
Bicyclic compound, production and use thereof Grant 8,741,943 - Shiraishi , et al. June 3, 2	2014-06-03
Bicyclic compound, production and use thereof Grant 8,362,058 - Shiraishi , et al. January 29, 2	2013-01-29
Bicyclic Compound, Production and Use Thereof App 20120232028 - SHIRAISHI; Mitsuru ; et al.	2012-09-13
Bicyclic compound, production and use thereof Grant 8,183,273 - Shiraishi , et al. May 22, 2	2012-05-22

Company Registrations

NCAGE Code	5R2P7	TOBIRA THERAPEUTICS, INC.
CAGE Code	5R2P7	TOBIRA THERAPEUTICS, INC.
DUNS	809034197	Tobira Therapeutics, Inc.
SEC	0001311596	Tobira Therapeutics, Inc. of DELAWARE
SEC	0001409690	Tobira Therapeutics, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.